AstraZeneca(us:AZN)
72.60
-1.22%
Updated on 2025-04-02
Open:74.00
Close:72.60
High:74.01
Low:72.42
Prev Close:73.50
Volume:4.73M
Turnover:344.23M
Turnover Ratio:0.15%
Shares:3.10B
MarketCap:225.15B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 56 | 920990 | 0.03% | 4 | 20 | 12 |
| 2024-03-31 | 1215 | 488337689 | 15.75% | 116 | 466 | 447 |
| 2023-12-31 | 1191 | 543196472 | 17.52% | 150 | 391 | 431 |
| 2023-09-30 | 1134 | 504605574 | 16.28% | 97 | 414 | 408 |
| 2023-06-30 | 1116 | 486198214 | 15.68% | 102 | 328 | 446 |
| 2023-03-31 | 1081 | 498624464 | 16.08% | 80 | 390 | 409 |
| 2022-12-31 | 1075 | 506509719 | 16.34% | 158 | 309 | 398 |
| 2022-09-30 | 1042 | 508951277 | 16.42% | 81 | 370 | 415 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Price T Rowe Associates Inc /Md/ | 64939661 | 2.09% | 3667687 | 5.99% |
| 2024-06-30 | Primecap Management Co/Ca/ | 42597235 | 1.37% | -347940 | -0.81% |
| 2024-06-30 | Wellington Management Group Llp | 40569917 | 1.31% | -8551944 | -17.41% |
| 2024-06-30 | Capital International Investors | 36703718 | 1.18% | 2181843 | 6.32% |
| 2024-06-30 | Fmr Llc | 22858970 | 0.74% | 2147309 | 10.37% |
| 2024-06-30 | Franklin Resources Inc | 17599960 | 0.57% | 377844 | 2.19% |
| 2024-06-30 | Jennison Associates Llc | 17023655 | 0.55% | -252627 | -1.46% |
| 2024-06-30 | Bank Of America Corp /De/ | 15860689 | 0.51% | 9635988 | 154.80% |
| 2024-06-30 | Sanders Capital, Llc | 14945242 | 0.48% | 126259 | 0.85% |
| 2024-06-30 | Goldman Sachs Group Inc | 12496350 | 0.40% | 210235 | 1.71% |
About
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Address:Cambridge Biomedical Campus,1 Francis Crick Avenue
Website:http://www.astrazeneca.co.uk
Market Movers